EU fund logo.

STOP – Surface Transfer of Pathogens

Research Center WANDER from Satakunta University of Applied Sciences is a partner in a Horizon Europe project “STOP – Surface Transfer of Pathogens". The STOP project will develop antimicrobial and antiviral nanocoatings that can be flexibly or permanently applied to high-touch surfaces. It is known that the transfer of pathogens can occur from various surfaces to hands and vice versa. Contamination through these surfaces is a potential threat to human health.  


1.9.2022 31.8.2026 

Total budget

4 311 278,13

Horizon Europe, European Commission

4 026 373,13 €



The STOP consortium consists of 15 organizations from 10 countries: Bulgaria, Croatia, Estonia, Finland Germany, Greece, Italy, Romania, Switzerland, and United Kingdom. The project is coordinated by the Bundesanstalt für Materialforschung und -prüfung, while it includes organizations, academic institutions, and government bodies with many years of experience in the fields of materials science, biology, health, and social care in Europe. 

Project's official site


Project Manager, Researching Principal Lecturer
Ms Merja Ahonen, PhD 
tel. +358 44 710 3061

Project objectives

  • Develop versatile and efficient nanomaterials that could be used as components of antimicrobial coatings for surfaces.
  • Significantly decrease the risk of pathogen transmissions from surfaces to hands and vice versa to STOP the spread of human infections.
  • Reduce healthcare costs.
  • Reduce environmental pollution by disinfectants.
  • Increase preparedness of the EU public health system to future pandemics.
STOP logo.

Projects activities

  • The nanocoatings will be derived from a combination of inorganic nanoparticles, antimicrobial peptides and nanoscale laser surface patterning.  
  • The nanocoatings will be thoroughly characterized for their efficacy, using both existing international standards and improved testing methods developed within the project.  
  • Several different active substances will be explored (i) to allow formulation in highly flexible, sprayable, and long-lasting coatings, (ii) provide broad spectrum antimicrobial antiviral activity, and iii) reduce the chances of the development of resistance.  
  • The efficiency of the nanocoatings will be studied in a real-life intervention trail and with epidemiological models.  
  • The safety of the nanomaterials will be backed up by human and environmental toxicity studies and life cycle analyses.  
  • Attention will be paid to end-user acceptance, manufacturing scalability, and short-term exploitation by SMEs.


BAM, Federal Institute for Materials Research and Testing

Affix Labs Oy

Amanuensis GmbH

Apel Laser SRL

Prolepsis Institute



The Foundation for Research and Technology - Hellas (FORTH)

Institute of Electronics Bulgarian Academy Of Sciences

King's College London
United Kingdom

Ruđer Bošković Institute

Satakunta University of Applied Sciences, Research Center WANDER

University of Tartu

University of Birmingham
United Kingdom

University of Trieste